Organika Health Products Inc. Chitosan Capsules
Organika Health Products Inc. Chitosan Capsules, NPN 80038785: natural health product licensed in Canada. Medicinal ingredients: (1-4)-2-Amino-2-deoxy-beta-D-glucan.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (1-4)-2-Amino-2-deoxy-beta-D-glucan Source : Crustacean Exoskeleton | 500 mg | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
To be used with a program of reduced intake in dietary calories and increased physical activity to help in weight management.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Consult a health care practitioner prior to use if you taking any prescription medicine. Consult a health care practitioner if you have diabetes. Discontinue use and consult a health care practitioner if you experience symptoms of hypoglycemia including feelings of anxiety, dizziness, tremor, sweating, nausea or headache. Consult a health care practitioner prior to use if you are taking blood thinners.
- Contra-Indications
Do not use if you are pregnant or breastfeeding. Do not use if you are allergic to seafood. Do not use if you are allergic to shellfish.
- Known Adverse Reactions
Some people may experience abdominal pain. Bloating, constipation, indigestion and diarrhea. If you have inflammatory or other chronic bowel disease, avoid use.
Product record
- Licence holder
- Organika Health Products Inc.
- NPN or DIN-HM
- 80038785
- Status
- Active licence
- Licence date
- 16 January 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80038785
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Organika Health Products Inc. Chitosan Capsules: composition and ingredients”, https://compoatlas.com/en/supplements/canada/80038785-organika-health-products-inc-chitosan-capsules, updated 16 January 2013.